Literature DB >> 8883423

Non-melanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study.

I Harvey1, S Frankel, R Marks, D Shalom, M Nolan-Farrell.   

Abstract

This study aimed to identify risk markers for prevalent solar keratoses (SKs) and squamous cell carcinomata (SCC) combined, for incident SKs and for spontaneous remission of SKs and to evaluate primary preventative measures. It was a cross-sectional study, with follow-up, conducted in South Wales, and involved 1034 subjects aged 60 years and over. The main outcome measures were the presence of and changes in SKs, and presence of skin cancers, on sun-exposed skin, and risk factors for prevalent SKs/SCCs and for incidence and remission of SKs. We found that variables independently associated with prevalent SKs/SCCs were: age [80 + years vs 60-64 years, odds ratio (OR) 3.7]; sex (male vs female OR 2.2); cumulative sun exposure (top quintile vs bottom quintile OR 3.3) and skin type (skin type 1 vs 4 OR 12.4). Use of sunscreen or protective clothing was not protective after controlling for confounders. Males and those who sunbathe infrequently showed greater remission of SKs. Older subjects and those spending most time in the sun in the preceeding 2 years were most likely to develop new SKs. We conclude that the risk factors identified are consistent with results from sunnier countries. The failure of sunscreen or clothing to emerge as protective raises doubts as to whether these measures are as effective in routine use in the general population as theoretical considerations and the limited trial evidence would predict. Recently reported sun exposure appears to influence the risk of developing new SKs.

Entities:  

Mesh:

Year:  1996        PMID: 8883423      PMCID: PMC2075911          DOI: 10.1038/bjc.1996.535

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Annual exposures to carcinogenic radiation from the sun at different latitudes and amplification factors related to ozone depletion. The use of different geometrical representations of the skin surface receiving the ultraviolet radiation.

Authors:  A Dahlback; J Moan
Journal:  Photochem Photobiol       Date:  1990-11       Impact factor: 3.421

2.  Spontaneous remission of solar keratoses: the case for conservative management.

Authors:  R Marks; P Foley; G Goodman; B H Hage; T S Selwood
Journal:  Br J Dermatol       Date:  1986-12       Impact factor: 9.302

3.  A re-appraisal of risk factors for skin carcinoma in Ireland. A case control study.

Authors:  C O'Loughlin; M J Moriarty; B Herity; L Daly
Journal:  Ir J Med Sci       Date:  1985-02       Impact factor: 1.568

4.  Reduction of solar keratoses by regular sunscreen use.

Authors:  S C Thompson; D Jolley; R Marks
Journal:  N Engl J Med       Date:  1993-10-14       Impact factor: 91.245

5.  The use of logistic regression for modelling risk factors: with application to non-melanoma skin cancer.

Authors:  P P Vitaliano
Journal:  Am J Epidemiol       Date:  1978-11       Impact factor: 4.897

6.  The relative importance of risk factors in nonmelanoma carcinoma.

Authors:  P P Vitaliano; F Urbach
Journal:  Arch Dermatol       Date:  1980-04

7.  High sun protection factor sunscreens in the suppression of actinic neoplasia.

Authors:  M F Naylor; A Boyd; D W Smith; G S Cameron; D Hubbard; K H Neldner
Journal:  Arch Dermatol       Date:  1995-02

8.  Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma.

Authors:  R P Gallagher; G B Hill; C D Bajdik; A J Coldman; S Fincham; D I McLean; W J Threlfall
Journal:  Arch Dermatol       Date:  1995-02

9.  Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma.

Authors:  R P Gallagher; G B Hill; C D Bajdik; S Fincham; A J Coldman; D I McLean; W J Threlfall
Journal:  Arch Dermatol       Date:  1995-02

10.  Melanoma and use of sunscreens: an Eortc case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group.

Authors:  P Autier; J F Doré; E Schifflers; J P Cesarini; A Bollaerts; K F Koelmel; O Gefeller; A Liabeuf; F Lejeune; D Lienard
Journal:  Int J Cancer       Date:  1995-06-09       Impact factor: 7.396

View more
  21 in total

Review 1.  Basal cell carcinoma.

Authors:  J T Lear; I Harvey; D de Berker; R C Strange; A A Fryer
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

2.  Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.

Authors:  Rebecca Gilbert; Chris Metcalfe; Steven E Oliver; David C Whiteman; Chris Bain; Andy Ness; Jenny Donovan; Freddie Hamdy; David E Neal; J Athene Lane; Richard M Martin
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

3.  Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans.

Authors:  Leonie C Jacobs; Andreas Wollstein; Oscar Lao; Albert Hofman; Caroline C Klaver; André G Uitterlinden; Tamar Nijsten; Manfred Kayser; Fan Liu
Journal:  Hum Genet       Date:  2012-10-11       Impact factor: 4.132

4.  Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma.

Authors:  Janine G Einspahr; Valerie Calvert; David S Alberts; Clara Curiel-Lewandrowski; James Warneke; Robert Krouse; Steven P Stratton; Lance Liotta; Caterina Longo; Giovanni Pellacani; Giovanni Pellicani; Anil Prasad; Paul Sagerman; Yira Bermudez; Jianghong Deng; G Timothy Bowden; Emanuel F Petricoin
Journal:  Cancer Prev Res (Phila)       Date:  2012-03

5.  The clinical course of actinic keratosis correlates with underlying molecular mechanisms.

Authors:  A Bakshi; R Shafi; J Nelson; W C Cantrell; S Subhadarshani; A Andea; M Athar; C A Elmets
Journal:  Br J Dermatol       Date:  2019-09-11       Impact factor: 9.302

Review 6.  Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis.

Authors:  S J Cooper; G T Bowden
Journal:  Curr Cancer Drug Targets       Date:  2007-06       Impact factor: 3.428

Review 7.  How to treat actinic keratosis? An update.

Authors:  Claudia Costa; Massimiliano Scalvenzi; Fabio Ayala; Gabriella Fabbrocini; Giuseppe Monfrecola
Journal:  J Dermatol Case Rep       Date:  2015-06-30

8.  Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes.

Authors:  C J Luscombe; M E French; S Liu; M F Saxby; P W Jones; A A Fryer; R C Strange
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640

9.  The role of ingenol mebutate in the treatment of actinic keratoses.

Authors:  Faisal R Ali; Christina Wlodek; John T Lear
Journal:  Dermatol Ther (Heidelb)       Date:  2012-06-07

10.  Primary care review of actinic keratosis and its therapeutic options: a global perspective.

Authors:  Praven Chetty; Felix Choi; Timothy Mitchell
Journal:  Dermatol Ther (Heidelb)       Date:  2015-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.